David Whitcombe
Non-executive Director
pharmaceutical sciences
cytox
Netherlands
Biography
David Whitcombe is a Venture Partner with Catapult Ventures, having worked alongside Catapult and its portfolio companies for a number of years informally. He has a wealth of experience in diagnostics and molecular biology and understands what it takes to grow a successful life science business. David co-founded DxS Diagnostics in 2000 to expand upon technology he developed at AstraZeneca, and sold the company in 2009 to Qiagen for in excess of £100m.
Research Interest
